JPS59101451A - 薬理学的に活性なペプチド - Google Patents

薬理学的に活性なペプチド

Info

Publication number
JPS59101451A
JPS59101451A JP58213150A JP21315083A JPS59101451A JP S59101451 A JPS59101451 A JP S59101451A JP 58213150 A JP58213150 A JP 58213150A JP 21315083 A JP21315083 A JP 21315083A JP S59101451 A JPS59101451 A JP S59101451A
Authority
JP
Japan
Prior art keywords
gly
tyr
phe
peptide
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58213150A
Other languages
English (en)
Japanese (ja)
Inventor
ロバ−ト・セオドア・シユ−マン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS59101451A publication Critical patent/JPS59101451A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP58213150A 1982-11-12 1983-11-11 薬理学的に活性なペプチド Pending JPS59101451A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US441137 1982-11-12
US06/441,137 US4448717A (en) 1982-11-12 1982-11-12 Pharmacologically active peptides

Publications (1)

Publication Number Publication Date
JPS59101451A true JPS59101451A (ja) 1984-06-12

Family

ID=23751694

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58213150A Pending JPS59101451A (ja) 1982-11-12 1983-11-11 薬理学的に活性なペプチド

Country Status (9)

Country Link
US (1) US4448717A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0112036A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS59101451A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR840007566A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK508983A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2130220B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR79019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU190915B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL70123A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263214A1 (en) * 1986-10-10 1988-04-13 E.I. Du Pont De Nemours And Company Tetrapeptide methyl ketone inhibitors of viral proteases
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198398A (en) * 1977-07-12 1980-04-15 Derek Hudson Enkephalin analogues
US4264491A (en) * 1977-10-03 1981-04-28 Eli Lilly And Company Analgesic compounds
GB2058077B (en) * 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
US4283330A (en) * 1979-12-17 1981-08-11 Eli Lilly And Company Pharmacologically active peptides
US4333873A (en) * 1979-12-17 1982-06-08 Eli Lilly And Company Pharmacologically active peptides
US4265808A (en) * 1979-12-17 1981-05-05 Eli Lilly And Company Pharmacologically active peptides
US4322340A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
IL70123A0 (en) 1984-02-29
KR840007566A (ko) 1984-12-08
DK508983A (da) 1984-05-13
US4448717A (en) 1984-05-15
GB8329995D0 (en) 1983-12-14
HU190915B (en) 1986-12-28
GB2130220A (en) 1984-05-31
DK508983D0 (da) 1983-11-07
GR79019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-10-02
EP0112036A1 (en) 1984-06-27
GB2130220B (en) 1986-05-29

Similar Documents

Publication Publication Date Title
Lipkowski et al. Double-enkephalins—synthesis, activity on guinea-pig ileum, and analgesic effect
US7589170B1 (en) Synthesis of cyclic peptides
JP3509029B2 (ja) 生物活性環化ポリペプチド
IE882185L (en) Lhrh antagonists
NO803640L (no) N-adamantan-substituerte tetrapeptidamider.
HU185320B (en) Process for producing biologically active encephaline analogous compounds
CA1187872A (en) Pharmacologically active peptides
JPS59101451A (ja) 薬理学的に活性なペプチド
JPS59170051A (ja) 薬理活性を有するトリペプチド誘導体
KR840001668B1 (ko) 펩티드의 제조방법
US4309343A (en) Pharmacologically active peptides
EP0291999A2 (en) Novel ANF derivatives
KR840001720B1 (ko) 펩타이드의 제조방법
HU186375B (en) Process for the preparation of biologically active encephalina derivatives
HU185022B (en) Process for the preparation of biologically active tetrapeptide derivatives
US4397842A (en) Peptides having thymopoietin-like activity
Chao et al. Preparation and use of the 4-[1-[N-(9-fluorenylmethyloxycarbonyl) amino]-2-(trimethylsilyl) ethyl] phenoxyacetic acid linkage agent for solid-phase synthesis of C-terminal peptide amides: improved yields of tryptophan-containing peptides
US4468383A (en) Dimeric enkephalins
WO1993000359A1 (en) Modified peptides transportable into the central nervous system
Snyder et al. Synthesis and opioid activity of dynorphin A-(1-13) NH2 analogs containing cis-and trans-4-aminocyclohexanecarboxylic acid
US4473497A (en) Pharmacologically active peptides
CA1247085A (en) Process for preparing n-carboxyalkylproline- containing tripeptides
KR860001909B1 (ko) 트리펩티드 유도체의 제조방법
JPH1160598A (ja) オピオイド様ペプチド
WO1990000564A1 (en) Peptides with extraordinary opioid receptor selectivity